ATE281172T1 - Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms - Google Patents

Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms

Info

Publication number
ATE281172T1
ATE281172T1 AT01936147T AT01936147T ATE281172T1 AT E281172 T1 ATE281172 T1 AT E281172T1 AT 01936147 T AT01936147 T AT 01936147T AT 01936147 T AT01936147 T AT 01936147T AT E281172 T1 ATE281172 T1 AT E281172T1
Authority
AT
Austria
Prior art keywords
choline
cdp
alcohol withdrawal
withdrawal syndrome
treat alcohol
Prior art date
Application number
AT01936147T
Other languages
English (en)
Inventor
Rafael Foguet
Jorge Ramentol
Rafael Lozano
Julian Agut
Jesus Torres
Manuel M Raga
Josep M Castell
Jose A Ortiz
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of ATE281172T1 publication Critical patent/ATE281172T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT01936147T 2000-03-29 2001-03-28 Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms ATE281172T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000765A ES2170649B1 (es) 2000-03-29 2000-03-29 Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
PCT/EP2001/003536 WO2001072288A2 (en) 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome

Publications (1)

Publication Number Publication Date
ATE281172T1 true ATE281172T1 (de) 2004-11-15

Family

ID=8492914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936147T ATE281172T1 (de) 2000-03-29 2001-03-28 Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms

Country Status (21)

Country Link
US (1) US6894032B2 (de)
EP (1) EP1267892B1 (de)
JP (1) JP4724348B2 (de)
KR (1) KR100794891B1 (de)
AT (1) ATE281172T1 (de)
AU (2) AU2001262141B2 (de)
BR (1) BR0109477A (de)
CA (1) CA2402707C (de)
CZ (1) CZ298933B6 (de)
DE (1) DE60106890T2 (de)
DK (1) DK1267892T3 (de)
ES (1) ES2170649B1 (de)
IL (2) IL151163A0 (de)
MX (1) MXPA02009442A (de)
NO (1) NO329766B1 (de)
NZ (1) NZ520825A (de)
PL (1) PL199291B1 (de)
PT (1) PT1267892E (de)
RU (1) RU2251422C2 (de)
WO (1) WO2001072288A2 (de)
ZA (1) ZA200206349B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1274444B1 (de) 2000-03-16 2013-05-15 THE McLEAN HOSPITAL CORPORATION Cdp-cholin und uridin zur behandlung von alkoholmissbrauch
AU2003252488A1 (en) * 2002-07-11 2004-02-02 Yamasa Corporation Medicinal composition for drug-induced neuropathy
WO2004043229A2 (en) 2002-11-08 2004-05-27 The Mclean Hospital Corporation Compounds for the treatment of tobacco dependence and withdrawal
UA88869C2 (ru) * 2002-12-20 2009-12-10 Зе Маклин Хоспитал Корпорейшн Соединения для нормализации цикла сон/бессонница
US20050129710A1 (en) * 2003-10-08 2005-06-16 Renshaw Perry F. Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids
US7737128B2 (en) 2004-06-10 2010-06-15 The Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US7947661B2 (en) 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308627A (en) * 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
DE4342173A1 (de) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
MX9700109A (es) * 1994-07-01 1997-04-30 Pro Neuron Inc Precursores nucleotidos de pirimidina para el tratamiento de inflamaciones sistemicas y hepatitis inflamatoria.
KR100217488B1 (ko) * 1997-06-03 1999-09-01 맹섭 골프채의 헤드커버
US5958896A (en) * 1997-08-08 1999-09-28 The Mclean Hospital Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
EP1274444B1 (de) 2000-03-16 2013-05-15 THE McLEAN HOSPITAL CORPORATION Cdp-cholin und uridin zur behandlung von alkoholmissbrauch

Also Published As

Publication number Publication date
NO329766B1 (no) 2010-12-13
EP1267892A2 (de) 2003-01-02
CZ298933B6 (cs) 2008-03-12
CA2402707A1 (en) 2001-10-04
BR0109477A (pt) 2003-06-03
US6894032B2 (en) 2005-05-17
CA2402707C (en) 2007-11-13
JP2003528133A (ja) 2003-09-24
MXPA02009442A (es) 2003-02-12
PL199291B1 (pl) 2008-09-30
US20030162749A1 (en) 2003-08-28
WO2001072288A3 (en) 2002-05-10
ZA200206349B (en) 2003-08-08
IL151163A (en) 2011-01-31
ES2170649A1 (es) 2002-08-01
NO20024574D0 (no) 2002-09-24
NZ520825A (en) 2004-04-30
IL151163A0 (en) 2003-04-10
ES2170649B1 (es) 2003-06-16
WO2001072288A2 (en) 2001-10-04
EP1267892B1 (de) 2004-11-03
DK1267892T3 (da) 2005-03-07
KR100794891B1 (ko) 2008-01-14
DE60106890D1 (de) 2004-12-09
PT1267892E (pt) 2005-03-31
AU6214101A (en) 2001-10-08
RU2002129579A (ru) 2004-03-27
PL363177A1 (en) 2004-11-15
DE60106890T2 (de) 2005-11-03
AU2001262141B2 (en) 2005-03-10
CZ20023245A3 (cs) 2003-03-12
NO20024574L (no) 2002-11-22
JP4724348B2 (ja) 2011-07-13
RU2251422C2 (ru) 2005-05-10
KR20030005248A (ko) 2003-01-17

Similar Documents

Publication Publication Date Title
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
HUP0101268A2 (hu) A női nemi diszfunkció kezelésére alkalmas gyógyszerkészítmények
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
HK1055117A1 (en) 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments.
GEP20053617B (en) Bridged Piperazine Derivatives
BG106155A (en) Novel derivatives and analogues of galanthamin
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE281172T1 (de) Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
EE200200088A (et) Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
HK1049169A1 (en) Substituted 4-benzylaminoquinolines, process for their preparation, pharmaceuticals containing thesecompounds and use thereof.
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
CY1107037T1 (el) Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
YU24603A (sh) Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267892

Country of ref document: EP